Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Wanhe Pharmaceutical is a specialized pharmaceutical manufacturer based in Nanjing, China, and serves as a major production and R&D hub for the Shenzhen Wanhe Pharmaceutical Group. The company focuses on therapeutic areas including gastroenterology, cardiovascular diseases, and respiratory health, with a particularly strong market presence in digestive health. Its commercial portfolio includes leading products such as Polyethylene Glycol 4000 for constipation and Trimebutine Maleate for gastrointestinal motility disorders. Jiangsu Wanhe is recognized as a National High-Tech Enterprise and operates multiple GMP-certified production lines for various dosage forms. The company is committed to the development of high-end generic drugs and innovative formulations to meet clinical needs in the Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Wanhe Pharmaceutical.